Shalev E

ORCID: 0000-0002-1084-3066 · 4 papers in corpus
other 2016
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-016-0146-0

BACKGROUND: In-vitro fertilization is a known risk factor for ectopic pregnancies. We sought to establish the risk factors for ectopic pregnancy in GnRH antagonist cycles examining patient and stimulation parameters with an emphasis on ovul…

other 2009
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-7-41

BACKGROUND: Although the MMP-2 promoter lacks a canonical progesterone response element (PRE), the hormone inhibits MMP-2 expression and is part of treatment protocols in gynecological invasive pathologies, including endometriosis and endom…

2009
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-7-152

BackgroundTo study the expression of Plexin-B1, Glycodelin, and MMP7 during the menstrual cycle in the endometrium and in the fallopian tube.MethodsThe research included women undergoing hysterectomy, tubal sterilization or salpingo-oophoer…

review 2003
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC ·doi:10.1016/s1701-2163(16)30206-7

The hypothalamic gonadotropin-releasing hormone (GnRH) is a key regulator of the reproductive system, mainly through its effects on pituitary luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release. Gonadotropin-releasing ho…